| JXSL2101081 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Import Drug Application | 2021-07-29 | | First Pharmaceutical (China) Co Ltd;Daiichi Sankyo Co Ltd | | | view |
| JXSL2101101 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Import Drug Application | 2021-08-24 | | Daiichi Sankyo Co Ltd;Astrazeneca Investment (China) Co Ltd | | | view |
| JXSL2101122 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Import Drug Application | 2021-11-01 | | First Pharmaceutical (China) Co Ltd;Daiichi Sankyo Co Ltd | | | view |
| JXSL2101124 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Import Drug Application | 2021-11-09 | | Daiichi Sankyo Co Ltd;Astrazeneca Investment (China) Co Ltd | | | view |
| JXSL2101147 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Import Drug Application | 2021-12-14 | | Daiichi Sankyo Co Ltd;Astrazeneca Investment (China) Co Ltd | | | view |
| JXSB2200053 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Supplementary Application | 2022-05-05 | | Daiichi Sankyo Co Ltd;Daiichi Sankyo Propharma Co Ltd | | | view |
| JXSB2200058 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Supplementary Application | 2022-05-24 | | Daiichi Sankyo Co Ltd;Daiichi Sankyo Propharma Co Ltd | | | view |
| JXSL2200072 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Import Drug Application | 2022-06-03 | | Daiichi Sankyo Co Ltd;Astrazeneca Investment (China) Co Ltd | | | view |
| JXSB2200067 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Supplementary Application | 2022-06-10 | | Daiichi Sankyo Co Ltd;Baxter Oncology GmbH | | | view |
| JXSL2200156 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Import Drug Application | 2022-09-08 | | First Pharmaceutical (China) Co Ltd;Daiichi Sankyo Co Ltd | | | view |
| JXSL2200166 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Import Drug Application | 2022-09-16 | | Daiichi Sankyo Co Ltd;Astrazeneca Investment (China) Co Ltd | | | view |
| JXSL2200174 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Import Drug Application | 2022-09-30 | | AstraZeneca AB;Astrazeneca Investment (China) Co Ltd | | | view |
| JTS2300008 | 注射用Datopotamab deruxtecan (DS-1062a) 100mg | datopotamab deruxtecan | Injection | Biological Products | Disposable Import Drug Application | 2023-03-10 | | Baxter Oncology GmbH;Daiichi Sankyo Europe GmbH;Daiichi Sankyo (CHINA) HOLDINGS Co Ltd | | | view |
| JTS2300009 | Datopotamab deruxtecan (DS-1062a)原液 | datopotamab deruxtecan | Active ingredient | Biological Products | Disposable Import Drug Application | 2023-03-10 | | Daiichi Sankyo Chemical Pharma Co Ltd Onahama Plant;Daiichi Sankyo Europe GmbH;Daiichi Sankyo (CHINA) HOLDINGS Co Ltd | | | view |
| JXSL2300051 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Import Drug Application | 2023-03-14 | | Daiichi Sankyo Co Ltd;Astrazeneca Investment (China) Co Ltd | | | view |
| JXSB2300083 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Supplementary Application | 2023-07-04 | | Daiichi Sankyo Co Ltd;Baxter Oncology GmbH | | | view |
| JXSL2300173 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Import Drug Application | 2023-10-09 | | Daiichi Sankyo Co Ltd;Astrazeneca Investment (China) Co Ltd | | | view |
| JXSL2300232 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Import Drug Application | 2023-12-22 | | Daiichi Sankyo Co Ltd;Astrazeneca Investment (China) Co Ltd | | | view |
| JXSB2400003 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Supplementary Application | 2024-01-16 | | AstraZeneca AB;Baxter Oncology GmbH | | | view |
| JXSB2400042 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Supplementary Application | 2024-04-22 | | Daiichi Sankyo Co Ltd;Baxter Oncology GmbH | | | view |
